Global CAR-T Cellular Immunotherapy Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 71

Published Date: 02 Jan 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global CAR-T Cellular Immunotherapy Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the CAR-T Cellular Immunotherapy Drug industry chain, the market status of Multiple Myeloma (CD19-Targeted, BCMA-Targeted), Non-Hodgkin lymphoma (CD19-Targeted, BCMA-Targeted), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of CAR-T Cellular Immunotherapy Drug.

Regionally, the report analyzes the CAR-T Cellular Immunotherapy Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global CAR-T Cellular Immunotherapy Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the CAR-T Cellular Immunotherapy Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the CAR-T Cellular Immunotherapy Drug industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., CD19-Targeted, BCMA-Targeted).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the CAR-T Cellular Immunotherapy Drug market.

Regional Analysis: The report involves examining the CAR-T Cellular Immunotherapy Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the CAR-T Cellular Immunotherapy Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to CAR-T Cellular Immunotherapy Drug:
Company Analysis: Report covers individual CAR-T Cellular Immunotherapy Drug players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards CAR-T Cellular Immunotherapy Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Multiple Myeloma, Non-Hodgkin lymphoma).

Technology Analysis: Report covers specific technologies relevant to CAR-T Cellular Immunotherapy Drug. It assesses the current state, advancements, and potential future developments in CAR-T Cellular Immunotherapy Drug areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the CAR-T Cellular Immunotherapy Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
CAR-T Cellular Immunotherapy Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
CD19-Targeted
BCMA-Targeted

Market segment by Application
Multiple Myeloma
Non-Hodgkin lymphoma
Leukemia

Market segment by players, this report covers
Novartis AG
Kite Pharma
Bristol Myers Squibb
Fosun Pharma

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe CAR-T Cellular Immunotherapy Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of CAR-T Cellular Immunotherapy Drug, with revenue, gross margin and global market share of CAR-T Cellular Immunotherapy Drug from 2019 to 2024.
Chapter 3, the CAR-T Cellular Immunotherapy Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and CAR-T Cellular Immunotherapy Drug market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of CAR-T Cellular Immunotherapy Drug.
Chapter 13, to describe CAR-T Cellular Immunotherapy Drug research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of CAR-T Cellular Immunotherapy Drug
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of CAR-T Cellular Immunotherapy Drug by Type
        1.3.1 Overview: Global CAR-T Cellular Immunotherapy Drug Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global CAR-T Cellular Immunotherapy Drug Consumption Value Market Share by Type in 2023
        1.3.3 CD19-Targeted
        1.3.4 BCMA-Targeted
    1.4 Global CAR-T Cellular Immunotherapy Drug Market by Application
        1.4.1 Overview: Global CAR-T Cellular Immunotherapy Drug Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Multiple Myeloma
        1.4.3 Non-Hodgkin lymphoma
        1.4.4 Leukemia
    1.5 Global CAR-T Cellular Immunotherapy Drug Market Size & Forecast
    1.6 Global CAR-T Cellular Immunotherapy Drug Market Size and Forecast by Region
        1.6.1 Global CAR-T Cellular Immunotherapy Drug Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global CAR-T Cellular Immunotherapy Drug Market Size by Region, (2019-2030)
        1.6.3 North America CAR-T Cellular Immunotherapy Drug Market Size and Prospect (2019-2030)
        1.6.4 Europe CAR-T Cellular Immunotherapy Drug Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific CAR-T Cellular Immunotherapy Drug Market Size and Prospect (2019-2030)
        1.6.6 South America CAR-T Cellular Immunotherapy Drug Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa CAR-T Cellular Immunotherapy Drug Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Novartis AG
        2.1.1 Novartis AG Details
        2.1.2 Novartis AG Major Business
        2.1.3 Novartis AG CAR-T Cellular Immunotherapy Drug Product and Solutions
        2.1.4 Novartis AG CAR-T Cellular Immunotherapy Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Novartis AG Recent Developments and Future Plans
    2.2 Kite Pharma
        2.2.1 Kite Pharma Details
        2.2.2 Kite Pharma Major Business
        2.2.3 Kite Pharma CAR-T Cellular Immunotherapy Drug Product and Solutions
        2.2.4 Kite Pharma CAR-T Cellular Immunotherapy Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Kite Pharma Recent Developments and Future Plans
    2.3 Bristol Myers Squibb
        2.3.1 Bristol Myers Squibb Details
        2.3.2 Bristol Myers Squibb Major Business
        2.3.3 Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Product and Solutions
        2.3.4 Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Bristol Myers Squibb Recent Developments and Future Plans
    2.4 Fosun Pharma
        2.4.1 Fosun Pharma Details
        2.4.2 Fosun Pharma Major Business
        2.4.3 Fosun Pharma CAR-T Cellular Immunotherapy Drug Product and Solutions
        2.4.4 Fosun Pharma CAR-T Cellular Immunotherapy Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Fosun Pharma Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global CAR-T Cellular Immunotherapy Drug Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of CAR-T Cellular Immunotherapy Drug by Company Revenue
        3.2.2 Top 3 CAR-T Cellular Immunotherapy Drug Players Market Share in 2023
        3.2.3 Top 6 CAR-T Cellular Immunotherapy Drug Players Market Share in 2023
    3.3 CAR-T Cellular Immunotherapy Drug Market: Overall Company Footprint Analysis
        3.3.1 CAR-T Cellular Immunotherapy Drug Market: Region Footprint
        3.3.2 CAR-T Cellular Immunotherapy Drug Market: Company Product Type Footprint
        3.3.3 CAR-T Cellular Immunotherapy Drug Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global CAR-T Cellular Immunotherapy Drug Consumption Value and Market Share by Type (2019-2024)
    4.2 Global CAR-T Cellular Immunotherapy Drug Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global CAR-T Cellular Immunotherapy Drug Consumption Value Market Share by Application (2019-2024)
    5.2 Global CAR-T Cellular Immunotherapy Drug Market Forecast by Application (2025-2030)

6 North America
    6.1 North America CAR-T Cellular Immunotherapy Drug Consumption Value by Type (2019-2030)
    6.2 North America CAR-T Cellular Immunotherapy Drug Consumption Value by Application (2019-2030)
    6.3 North America CAR-T Cellular Immunotherapy Drug Market Size by Country
        6.3.1 North America CAR-T Cellular Immunotherapy Drug Consumption Value by Country (2019-2030)
        6.3.2 United States CAR-T Cellular Immunotherapy Drug Market Size and Forecast (2019-2030)
        6.3.3 Canada CAR-T Cellular Immunotherapy Drug Market Size and Forecast (2019-2030)
        6.3.4 Mexico CAR-T Cellular Immunotherapy Drug Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe CAR-T Cellular Immunotherapy Drug Consumption Value by Type (2019-2030)
    7.2 Europe CAR-T Cellular Immunotherapy Drug Consumption Value by Application (2019-2030)
    7.3 Europe CAR-T Cellular Immunotherapy Drug Market Size by Country
        7.3.1 Europe CAR-T Cellular Immunotherapy Drug Consumption Value by Country (2019-2030)
        7.3.2 Germany CAR-T Cellular Immunotherapy Drug Market Size and Forecast (2019-2030)
        7.3.3 France CAR-T Cellular Immunotherapy Drug Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom CAR-T Cellular Immunotherapy Drug Market Size and Forecast (2019-2030)
        7.3.5 Russia CAR-T Cellular Immunotherapy Drug Market Size and Forecast (2019-2030)
        7.3.6 Italy CAR-T Cellular Immunotherapy Drug Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific CAR-T Cellular Immunotherapy Drug Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific CAR-T Cellular Immunotherapy Drug Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific CAR-T Cellular Immunotherapy Drug Market Size by Region
        8.3.1 Asia-Pacific CAR-T Cellular Immunotherapy Drug Consumption Value by Region (2019-2030)
        8.3.2 China CAR-T Cellular Immunotherapy Drug Market Size and Forecast (2019-2030)
        8.3.3 Japan CAR-T Cellular Immunotherapy Drug Market Size and Forecast (2019-2030)
        8.3.4 South Korea CAR-T Cellular Immunotherapy Drug Market Size and Forecast (2019-2030)
        8.3.5 India CAR-T Cellular Immunotherapy Drug Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia CAR-T Cellular Immunotherapy Drug Market Size and Forecast (2019-2030)
        8.3.7 Australia CAR-T Cellular Immunotherapy Drug Market Size and Forecast (2019-2030)

9 South America
    9.1 South America CAR-T Cellular Immunotherapy Drug Consumption Value by Type (2019-2030)
    9.2 South America CAR-T Cellular Immunotherapy Drug Consumption Value by Application (2019-2030)
    9.3 South America CAR-T Cellular Immunotherapy Drug Market Size by Country
        9.3.1 South America CAR-T Cellular Immunotherapy Drug Consumption Value by Country (2019-2030)
        9.3.2 Brazil CAR-T Cellular Immunotherapy Drug Market Size and Forecast (2019-2030)
        9.3.3 Argentina CAR-T Cellular Immunotherapy Drug Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa CAR-T Cellular Immunotherapy Drug Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa CAR-T Cellular Immunotherapy Drug Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa CAR-T Cellular Immunotherapy Drug Market Size by Country
        10.3.1 Middle East & Africa CAR-T Cellular Immunotherapy Drug Consumption Value by Country (2019-2030)
        10.3.2 Turkey CAR-T Cellular Immunotherapy Drug Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia CAR-T Cellular Immunotherapy Drug Market Size and Forecast (2019-2030)
        10.3.4 UAE CAR-T Cellular Immunotherapy Drug Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 CAR-T Cellular Immunotherapy Drug Market Drivers
    11.2 CAR-T Cellular Immunotherapy Drug Market Restraints
    11.3 CAR-T Cellular Immunotherapy Drug Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 CAR-T Cellular Immunotherapy Drug Industry Chain
    12.2 CAR-T Cellular Immunotherapy Drug Upstream Analysis
    12.3 CAR-T Cellular Immunotherapy Drug Midstream Analysis
    12.4 CAR-T Cellular Immunotherapy Drug Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global CAR-T Cellular Immunotherapy Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global CAR-T Cellular Immunotherapy Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global CAR-T Cellular Immunotherapy Drug Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global CAR-T Cellular Immunotherapy Drug Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Novartis AG Company Information, Head Office, and Major Competitors
    Table 6. Novartis AG Major Business
    Table 7. Novartis AG CAR-T Cellular Immunotherapy Drug Product and Solutions
    Table 8. Novartis AG CAR-T Cellular Immunotherapy Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Novartis AG Recent Developments and Future Plans
    Table 10. Kite Pharma Company Information, Head Office, and Major Competitors
    Table 11. Kite Pharma Major Business
    Table 12. Kite Pharma CAR-T Cellular Immunotherapy Drug Product and Solutions
    Table 13. Kite Pharma CAR-T Cellular Immunotherapy Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Kite Pharma Recent Developments and Future Plans
    Table 15. Bristol Myers Squibb Company Information, Head Office, and Major Competitors
    Table 16. Bristol Myers Squibb Major Business
    Table 17. Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Product and Solutions
    Table 18. Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Bristol Myers Squibb Recent Developments and Future Plans
    Table 20. Fosun Pharma Company Information, Head Office, and Major Competitors
    Table 21. Fosun Pharma Major Business
    Table 22. Fosun Pharma CAR-T Cellular Immunotherapy Drug Product and Solutions
    Table 23. Fosun Pharma CAR-T Cellular Immunotherapy Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Fosun Pharma Recent Developments and Future Plans
    Table 25. Global CAR-T Cellular Immunotherapy Drug Revenue (USD Million) by Players (2019-2024)
    Table 26. Global CAR-T Cellular Immunotherapy Drug Revenue Share by Players (2019-2024)
    Table 27. Breakdown of CAR-T Cellular Immunotherapy Drug by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 28. Market Position of Players in CAR-T Cellular Immunotherapy Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 29. Head Office of Key CAR-T Cellular Immunotherapy Drug Players
    Table 30. CAR-T Cellular Immunotherapy Drug Market: Company Product Type Footprint
    Table 31. CAR-T Cellular Immunotherapy Drug Market: Company Product Application Footprint
    Table 32. CAR-T Cellular Immunotherapy Drug New Market Entrants and Barriers to Market Entry
    Table 33. CAR-T Cellular Immunotherapy Drug Mergers, Acquisition, Agreements, and Collaborations
    Table 34. Global CAR-T Cellular Immunotherapy Drug Consumption Value (USD Million) by Type (2019-2024)
    Table 35. Global CAR-T Cellular Immunotherapy Drug Consumption Value Share by Type (2019-2024)
    Table 36. Global CAR-T Cellular Immunotherapy Drug Consumption Value Forecast by Type (2025-2030)
    Table 37. Global CAR-T Cellular Immunotherapy Drug Consumption Value by Application (2019-2024)
    Table 38. Global CAR-T Cellular Immunotherapy Drug Consumption Value Forecast by Application (2025-2030)
    Table 39. North America CAR-T Cellular Immunotherapy Drug Consumption Value by Type (2019-2024) & (USD Million)
    Table 40. North America CAR-T Cellular Immunotherapy Drug Consumption Value by Type (2025-2030) & (USD Million)
    Table 41. North America CAR-T Cellular Immunotherapy Drug Consumption Value by Application (2019-2024) & (USD Million)
    Table 42. North America CAR-T Cellular Immunotherapy Drug Consumption Value by Application (2025-2030) & (USD Million)
    Table 43. North America CAR-T Cellular Immunotherapy Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 44. North America CAR-T Cellular Immunotherapy Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 45. Europe CAR-T Cellular Immunotherapy Drug Consumption Value by Type (2019-2024) & (USD Million)
    Table 46. Europe CAR-T Cellular Immunotherapy Drug Consumption Value by Type (2025-2030) & (USD Million)
    Table 47. Europe CAR-T Cellular Immunotherapy Drug Consumption Value by Application (2019-2024) & (USD Million)
    Table 48. Europe CAR-T Cellular Immunotherapy Drug Consumption Value by Application (2025-2030) & (USD Million)
    Table 49. Europe CAR-T Cellular Immunotherapy Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 50. Europe CAR-T Cellular Immunotherapy Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 51. Asia-Pacific CAR-T Cellular Immunotherapy Drug Consumption Value by Type (2019-2024) & (USD Million)
    Table 52. Asia-Pacific CAR-T Cellular Immunotherapy Drug Consumption Value by Type (2025-2030) & (USD Million)
    Table 53. Asia-Pacific CAR-T Cellular Immunotherapy Drug Consumption Value by Application (2019-2024) & (USD Million)
    Table 54. Asia-Pacific CAR-T Cellular Immunotherapy Drug Consumption Value by Application (2025-2030) & (USD Million)
    Table 55. Asia-Pacific CAR-T Cellular Immunotherapy Drug Consumption Value by Region (2019-2024) & (USD Million)
    Table 56. Asia-Pacific CAR-T Cellular Immunotherapy Drug Consumption Value by Region (2025-2030) & (USD Million)
    Table 57. South America CAR-T Cellular Immunotherapy Drug Consumption Value by Type (2019-2024) & (USD Million)
    Table 58. South America CAR-T Cellular Immunotherapy Drug Consumption Value by Type (2025-2030) & (USD Million)
    Table 59. South America CAR-T Cellular Immunotherapy Drug Consumption Value by Application (2019-2024) & (USD Million)
    Table 60. South America CAR-T Cellular Immunotherapy Drug Consumption Value by Application (2025-2030) & (USD Million)
    Table 61. South America CAR-T Cellular Immunotherapy Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 62. South America CAR-T Cellular Immunotherapy Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 63. Middle East & Africa CAR-T Cellular Immunotherapy Drug Consumption Value by Type (2019-2024) & (USD Million)
    Table 64. Middle East & Africa CAR-T Cellular Immunotherapy Drug Consumption Value by Type (2025-2030) & (USD Million)
    Table 65. Middle East & Africa CAR-T Cellular Immunotherapy Drug Consumption Value by Application (2019-2024) & (USD Million)
    Table 66. Middle East & Africa CAR-T Cellular Immunotherapy Drug Consumption Value by Application (2025-2030) & (USD Million)
    Table 67. Middle East & Africa CAR-T Cellular Immunotherapy Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 68. Middle East & Africa CAR-T Cellular Immunotherapy Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 69. CAR-T Cellular Immunotherapy Drug Raw Material
    Table 70. Key Suppliers of CAR-T Cellular Immunotherapy Drug Raw Materials
List of Figures
    Figure 1. CAR-T Cellular Immunotherapy Drug Picture
    Figure 2. Global CAR-T Cellular Immunotherapy Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global CAR-T Cellular Immunotherapy Drug Consumption Value Market Share by Type in 2023
    Figure 4. CD19-Targeted
    Figure 5. BCMA-Targeted
    Figure 6. Global CAR-T Cellular Immunotherapy Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 7. CAR-T Cellular Immunotherapy Drug Consumption Value Market Share by Application in 2023
    Figure 8. Multiple Myeloma Picture
    Figure 9. Non-Hodgkin lymphoma Picture
    Figure 10. Leukemia Picture
    Figure 11. Global CAR-T Cellular Immunotherapy Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 12. Global CAR-T Cellular Immunotherapy Drug Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 13. Global Market CAR-T Cellular Immunotherapy Drug Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 14. Global CAR-T Cellular Immunotherapy Drug Consumption Value Market Share by Region (2019-2030)
    Figure 15. Global CAR-T Cellular Immunotherapy Drug Consumption Value Market Share by Region in 2023
    Figure 16. North America CAR-T Cellular Immunotherapy Drug Consumption Value (2019-2030) & (USD Million)
    Figure 17. Europe CAR-T Cellular Immunotherapy Drug Consumption Value (2019-2030) & (USD Million)
    Figure 18. Asia-Pacific CAR-T Cellular Immunotherapy Drug Consumption Value (2019-2030) & (USD Million)
    Figure 19. South America CAR-T Cellular Immunotherapy Drug Consumption Value (2019-2030) & (USD Million)
    Figure 20. Middle East and Africa CAR-T Cellular Immunotherapy Drug Consumption Value (2019-2030) & (USD Million)
    Figure 21. Global CAR-T Cellular Immunotherapy Drug Revenue Share by Players in 2023
    Figure 22. CAR-T Cellular Immunotherapy Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 23. Global Top 3 Players CAR-T Cellular Immunotherapy Drug Market Share in 2023
    Figure 24. Global Top 6 Players CAR-T Cellular Immunotherapy Drug Market Share in 2023
    Figure 25. Global CAR-T Cellular Immunotherapy Drug Consumption Value Share by Type (2019-2024)
    Figure 26. Global CAR-T Cellular Immunotherapy Drug Market Share Forecast by Type (2025-2030)
    Figure 27. Global CAR-T Cellular Immunotherapy Drug Consumption Value Share by Application (2019-2024)
    Figure 28. Global CAR-T Cellular Immunotherapy Drug Market Share Forecast by Application (2025-2030)
    Figure 29. North America CAR-T Cellular Immunotherapy Drug Consumption Value Market Share by Type (2019-2030)
    Figure 30. North America CAR-T Cellular Immunotherapy Drug Consumption Value Market Share by Application (2019-2030)
    Figure 31. North America CAR-T Cellular Immunotherapy Drug Consumption Value Market Share by Country (2019-2030)
    Figure 32. United States CAR-T Cellular Immunotherapy Drug Consumption Value (2019-2030) & (USD Million)
    Figure 33. Canada CAR-T Cellular Immunotherapy Drug Consumption Value (2019-2030) & (USD Million)
    Figure 34. Mexico CAR-T Cellular Immunotherapy Drug Consumption Value (2019-2030) & (USD Million)
    Figure 35. Europe CAR-T Cellular Immunotherapy Drug Consumption Value Market Share by Type (2019-2030)
    Figure 36. Europe CAR-T Cellular Immunotherapy Drug Consumption Value Market Share by Application (2019-2030)
    Figure 37. Europe CAR-T Cellular Immunotherapy Drug Consumption Value Market Share by Country (2019-2030)
    Figure 38. Germany CAR-T Cellular Immunotherapy Drug Consumption Value (2019-2030) & (USD Million)
    Figure 39. France CAR-T Cellular Immunotherapy Drug Consumption Value (2019-2030) & (USD Million)
    Figure 40. United Kingdom CAR-T Cellular Immunotherapy Drug Consumption Value (2019-2030) & (USD Million)
    Figure 41. Russia CAR-T Cellular Immunotherapy Drug Consumption Value (2019-2030) & (USD Million)
    Figure 42. Italy CAR-T Cellular Immunotherapy Drug Consumption Value (2019-2030) & (USD Million)
    Figure 43. Asia-Pacific CAR-T Cellular Immunotherapy Drug Consumption Value Market Share by Type (2019-2030)
    Figure 44. Asia-Pacific CAR-T Cellular Immunotherapy Drug Consumption Value Market Share by Application (2019-2030)
    Figure 45. Asia-Pacific CAR-T Cellular Immunotherapy Drug Consumption Value Market Share by Region (2019-2030)
    Figure 46. China CAR-T Cellular Immunotherapy Drug Consumption Value (2019-2030) & (USD Million)
    Figure 47. Japan CAR-T Cellular Immunotherapy Drug Consumption Value (2019-2030) & (USD Million)
    Figure 48. South Korea CAR-T Cellular Immunotherapy Drug Consumption Value (2019-2030) & (USD Million)
    Figure 49. India CAR-T Cellular Immunotherapy Drug Consumption Value (2019-2030) & (USD Million)
    Figure 50. Southeast Asia CAR-T Cellular Immunotherapy Drug Consumption Value (2019-2030) & (USD Million)
    Figure 51. Australia CAR-T Cellular Immunotherapy Drug Consumption Value (2019-2030) & (USD Million)
    Figure 52. South America CAR-T Cellular Immunotherapy Drug Consumption Value Market Share by Type (2019-2030)
    Figure 53. South America CAR-T Cellular Immunotherapy Drug Consumption Value Market Share by Application (2019-2030)
    Figure 54. South America CAR-T Cellular Immunotherapy Drug Consumption Value Market Share by Country (2019-2030)
    Figure 55. Brazil CAR-T Cellular Immunotherapy Drug Consumption Value (2019-2030) & (USD Million)
    Figure 56. Argentina CAR-T Cellular Immunotherapy Drug Consumption Value (2019-2030) & (USD Million)
    Figure 57. Middle East and Africa CAR-T Cellular Immunotherapy Drug Consumption Value Market Share by Type (2019-2030)
    Figure 58. Middle East and Africa CAR-T Cellular Immunotherapy Drug Consumption Value Market Share by Application (2019-2030)
    Figure 59. Middle East and Africa CAR-T Cellular Immunotherapy Drug Consumption Value Market Share by Country (2019-2030)
    Figure 60. Turkey CAR-T Cellular Immunotherapy Drug Consumption Value (2019-2030) & (USD Million)
    Figure 61. Saudi Arabia CAR-T Cellular Immunotherapy Drug Consumption Value (2019-2030) & (USD Million)
    Figure 62. UAE CAR-T Cellular Immunotherapy Drug Consumption Value (2019-2030) & (USD Million)
    Figure 63. CAR-T Cellular Immunotherapy Drug Market Drivers
    Figure 64. CAR-T Cellular Immunotherapy Drug Market Restraints
    Figure 65. CAR-T Cellular Immunotherapy Drug Market Trends
    Figure 66. Porters Five Forces Analysis
    Figure 67. Manufacturing Cost Structure Analysis of CAR-T Cellular Immunotherapy Drug in 2023
    Figure 68. Manufacturing Process Analysis of CAR-T Cellular Immunotherapy Drug
    Figure 69. CAR-T Cellular Immunotherapy Drug Industrial Chain
    Figure 70. Methodology
    Figure 71. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Novartis AG
Kite Pharma
Bristol Myers Squibb
Fosun Pharma

Related Reports

Global CAR-T Cellular Immunotherapy Drug Supply, Demand and Key Producers, 2023-2029

Global CAR-T Cellular Immunotherapy Drug Supply, Demand and Key Producers, 2023-2029

date 02 Sep 2023

date Medical Care

The global CAR-T Cellular Immunotherapy Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global CAR-T Cellular Immunotherapy Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global CAR-T Cellular Immunotherapy Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 02 Sep 2023

date Medical Care

According to our (Global Info Research) latest study, the global CAR-T Cellular Immunotherapy Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

Global CAR-T Cellular Immunotherapy Drug Supply, Demand and Key Producers, 2024-2030

Global CAR-T Cellular Immunotherapy Drug Supply, Demand and Key Producers, 2024-2030

date 09 Feb 2024

date Medical Care

The global CAR-T Cellular Immunotherapy Drug market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

CAR-T Cellular Immunotherapy Drug

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>